Cancer patients who responded to drug get continued access in rollover trial
NCT ID NCT06506955
First seen Mar 11, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This study offers ongoing futibatinib treatment to about 15 people with advanced or metastatic cancer who were already benefiting from the drug in a previous study. The main goal is to track long-term safety, including side effects. Participants continue their current dose as long as they are doing well and the risks are acceptable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED/METASTATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centro Integral Oncologico
Madrid, 28050, Spain
-
Hospital Universitari, Vall d'Hebron
Barcelona, 8035, Spain
-
Institut De Cancerologie Strasbourg
Strasbourg, 67033, France
-
Institut Paoli-Calmettes
Marseille, 13009, France
-
Royal Marsden NHS Foundation Trust
London, SW3 6JJ, United Kingdom
-
Sarah Cannon Research Institute UK
London, W1G 6AD, United Kingdom
-
Severance Hospital
Seoul, 3722, South Korea
-
University College London Hospitals NHS Foundation Trust
London, W1T 7HA, United Kingdom
-
University of California, San Francisco (UCSF)
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.